New code requires doctors to disclose all links with drug industryBMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.d2188 (Published 05 April 2011) Cite this as: BMJ 2011;342:d2188
- Clare Dyer
Doctors who contract after 1 May to act as consultants or advisers to drug companies in the United Kingdom will be obliged to declare the arrangement whenever they write or speak in public on any issue relating to the company, under new industry rules.
From next year companies will also have to disclose the total amounts paid to consultants and the number of recipients, although the consultants will not have to be named.
The rules form part of the 2011 code of practice of the Association of the British Pharmaceutical Industry. Important changes include new rules …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial